Update On The CRISPR IP Saga And Lessons To Be Learnt
This seminar will provide an overview of the CRISPR IP saga, discussion of considerations in relation to freedom-to-operate for use of the technology and an update on the lessons to be learnt from the IP issues which have inflicted major costs on those involved. Thursday 27th June, Der Teufelhof Basel, 6pm CRISPR gene-editing continues to hit headlines regularly as a ground-breaking technology with many millions now flowing into companies seeking to exploit the technology [...]